Nike's stock surged after J.P. Morgan upgraded it to Overweight from Neutral, raising its price target to $93, citing a "five-pronged multiyear recovery path." Analyst Matthew Boss highlighted catalysts including the 2026 World Cup, improved inventory alignment, and projected high-teens to 20% EPS growth, alongside a significant operating margin recovery, signaling a strong re-acceleration for the sportswear giant.
Nike's stock (NKE) is showing significant momentum following a strategic upgrade to Overweight from Neutral by J.P. Morgan, which triggered a 2.7% intraday rally. The upgrade is supported by a new, higher price target of $93, implying approximately 19% upside from current levels, and reflects a strong recent stock recovery of 47.1% from its eight-year low on April 8. The core of the bullish thesis is a detailed "five-pronged multiyear recovery path" based on conversations with Nike's management. Key drivers include the 2026 World Cup as a major sales catalyst, the normalization of global inventory relative to sales growth by Q2 2026, and a robust product innovation pipeline in running and footwear that is now offsetting declines in classic franchises. Financially, this strategy is projected to deliver high-teens to 20% EPS growth over the next five years and a significant operating margin recovery from a projected 5.3% in fiscal 2026 to 10% within three years, with a long-term goal of reaching pre-pandemic levels of 12-13%. This suggests an inflection point for revenue re-acceleration in the second half of 2026, following several quarters of inventory management headwinds.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment